Top Abstract Purchase Related
Home
>
Node
>
Subnode

Overview of generalized anxiety disorder in the elderly

Schneider, L.S.

Journal of Clinical Psychiatry 57(Suppl 7) 34-45; Discussion: 52-54

1996

ISSN/ISBN: 0160-6689
PMID: 8690695
Document Number: 455601
Both situational anxiety and pathologic anxiety are common in the elderly. Pathologic anxiety, however, may significantly disable a previously functioning older adult. Moderate-to-severe anxiety is important to accurately diagnose and treat in older persons in order to improve daily functioning and because individual symptoms of anxiety can be easily confused with even more severe geropsychiatric disorders such as dementia, delirium, depression, and psychosis. These particular symptoms include impaired concentration and attention, impaired memory, dizziness, disabling fear, severe insomnia, and hypervigilance, among others. This article will review epidemiology, characteristics of anxiety in late-life, patterns of medication use, and treatment.

Document emailed within 1 workday
Secure & encrypted payments

Mossman, S.A.; Luft, M.J.; Schroeder, H.K.; Varney, S.T.; Fleck, D.E.; Barzman, D.H.; Gilman, R.; DelBello, M.P.; Strawn, J.R. 2017: The Generalized Anxiety Disorder 7-item scale in adolescents with generalized anxiety disorder: Signal detection and validation Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 29(4): 227-234a
Biebl, W.; Deisenhammer, E.A.; Lehofer, M.; Muigg, W.; Posch, C.; Zeilerbauer, J. 1993: Anxiety neurosis--avoidant behavior--depression. a comparison between panic disorder and generalized anxiety disorder Psychotherapie Psychosomatik Medizinische Psychologie 43(1): 10-14
Ballenger, J.C.; Davidson, J.R.; Lecrubier, Y.; Nutt, D.J.; Borkovec, T.D.; Rickels, K.; Stein, D.J.; Wittchen, H.U. 2001: Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety Journal of Clinical Psychiatry 62(Suppl): 53-58
Gasparini, M.; Dalla Pria, S.; D'Aietti, V. 1987: Generalized anxiety disorder in labor Minerva Ginecologica 39(3): 141-144
Brawman-Mintzer, O.; Lydiard, R.B. 1997: Biological basis of generalized anxiety disorder Journal of Clinical Psychiatry 58(Suppl): 16-25
Berber, M.J. 2000: WATCHERS: recognizing generalized anxiety disorder Journal of Clinical Psychiatry 61(6): 447
Vanderlaan, J. 2008: Pregnancy and birth with generalized anxiety disorder Midwifery Today with International Midwife 88: 28-29; 67-68
Ninan, P.T. 2001: Generalized anxiety disorder: diagnosis, neurobiology, and treatment Psychopharmacology Bulletin 35(1): 65-76
Kamrowska, A.; Gmitrowicz, A. 2016: Treatment of generalized anxiety disorder in terms of cognitive behavioral Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 40(236): 141-143
Pollack, M.H. 2001: Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission Journal of Clinical Psychiatry 62(Suppl): 20-25
2012: Pharmacotherapy versus psychotherapy: treatment of generalized anxiety disorder MMW Fortschritte der Medizin 154(2): 78-79
Schweizer, E.; Rickels, K. 1996: The long-term management of generalized anxiety disorder: issues and dilemmas Journal of Clinical Psychiatry 57(Suppl): 9
Starcevic, V.; Fallon, S.; Uhlenhuth, E.H. 1994: The frequency and severity of generalized anxiety disorder symptoms. Toward a less cumbersome conceptualization Journal of Nervous and Mental Disease 182(2): 80-84
Othmer, E.; Othmer, S.C. 1987: Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder Journal of Clinical Psychiatry 48(5): 201-203
Hedges, D.W.; Reimherr, F.W.; Strong, R.E.; Halls, C.H.; Rust, C. 1996: An open trial of nefazodone in adult patients with generalized anxiety disorder Psychopharmacology Bulletin 32(4): 671-676
Bystritsky, A.; Kerwin, L.; Feusner, J.D.; Vapnik, T. 2008: A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder Psychopharmacology Bulletin 41(1): 46-51
Allgulander, C.; Cloninger, C.R.; Przybeck, T.R.; Brandt, L. 1998: Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder Psychopharmacology Bulletin 34(2): 165-166
Bereza, B.G.; Machado, Márcio.; Ravindran, A.V.; Einarson, T.R. 2012: Evidence-based review of clinical outcomes of guideline-recommended pharmacotherapies for generalized anxiety disorder Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 57(8): 470-478
Ballenger, J.C.; McDonald, S.; Noyes, R.; Rickels, K.; Sussman, N.; Woods, S.; Patin, J.; Singer, J. 1991: The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder Psychopharmacology Bulletin 27(2): 171-179
Cardona-Castrillon, G.P.; Isaza, R.; Zapata-Soto, A.P.; Franco, J.G.; Gonzalez-Berrio, C.; Tamayo-Diaz, C.P. 2007: The comorbidity of major depressive disorder, dysthymic disorder and anxiety disorders with migraine Revista de Neurologia 45(5): 272-275